Announcements Trials
Browse Landscape

Phase

Phase 2 2Phase 1/2 2

Status

Terminated 1Completed 1

Sponsor Class

OTHER 2

Study Type

Interventional 2

Sponsor

Cancer Type

Lymphoid 2Dermatologic 2

Conditions

Sezary Syndrome 2Mycosis Fungoides 2Lymphoma, T-Cell, Cutaneous 2Neoplasms 1Leukemia 1Immunologic Deficiency Syndromes 1Hemoglobinopathies 1

Interventions

fludarabine phosphate 4Peripheral Blood Stem Cell Transplantation 4Rituximab 3Immunoglobulin G 3Everolimus 3Disulfides 3Cyclosporine 3mogamulizumab 2Whole-Body Irradiation 2Tacrolimus 2Photopheresis 2Mycophenolic Acid 2Methotrexate 2Lenalidomide 2Gene Expression Profiling 2Etoposide 2Cyclophosphamide 2Busulfan 2Bortezomib 2veliparib 1navitoclax 1magrolimab 1liposomal doxorubicin 1indolepropanol phosphate 1fludarabine 1flt3 ligand protein 1ethanolamine oleate 1durvalumab 1carmustine, poliferprosan 20 drug combination 1alvocidib 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Phase 1/2 × Sezary Syndrome × Photopheresis × Clear all
NCT04676087 2024-08-13

Mogamulizumab and Extracorporeal Photopheresis for the Treatment of Sezary Syndrome or Mycosis Fungoides

Emory University

Phase 1/2 Terminated
5 enrolled
DermatologicLymphoid

Mycosis Fungoides, Sezary Syndrome, Lymphoma, T-Cell, Cutaneous

NCT00306969 2006-03-27

Study of Oral Bexarotene in Combination With Photopheresis for Treatment of Cutaneous T-Cell Lymphoma

Boston University

Phase 1/2 Completed
18 enrolled
DermatologicLymphoid

Mycosis Fungoides, Sezary Syndrome, Lymphoma, T-Cell, Cutaneous

Data powered by HemOnc (CC BY 4.0) Colophon âš¡